Anxiety and depression among cancer patients: prevalence and associated factors at a Rwandan referral hospital
Background: Cancer patients frequently experience psychological problems related to reactions of cancer diagnosis, cancer type, treatment effects, recurrence, fear of end-of-life, survivorship, and financial burden. Psychological assessment has been integrated into cancer care in some countries, but there is limited knowledge about the practice in Rwanda.
Objective: To assess the prevalence and associated factors of anxiety and depression among patients with cancer attending a private referral hospital in Rwanda.
Methods: A descriptive cross-sectional study design was used with the Hospital Anxiety and Depression Scale (HADS) instrument to assess cancer patients. A probability systematic random sampling technique was used to recruit 96 patients. Data were analysed using descriptive statistics to determine the association of variables with anxiety and depression.
Results: The majority of cancer patients had depression (67.7%) and anxiety (52.1%). Anxiety was associated with employment status (p=0.02), cancer stage (p=0.02), weight loss (p=0.00) and depression (p=0.00). Depression was associated with cancer stage (p=0.02), pain (p=0.03), weight loss (p= 0.03), cancer treatment (p=0.02) and anxiety (p=0.001).
Conclusion: Anxiety and depression were reported in over half of the study population indicating a need to create and integrate psycho-oncology into standard oncology care.
Keywords: Cancer, anxiety, depression, prevalence, associated factors
During the submission, authors will be requested to complete a ‘Copyright Transfer form' to assign to the University of Rwanda the copyright of the manuscript and any tables, illustrations or other material submitted for publication as part of the manuscript (the "Article") in all forms and media (whether now known or later developed), throughout the world, in all languages, for the full term of copyright, effective when the article is accepted for publication. The Creative Commons Attribution NonCommercial-NoDerivs (CC-BY-NC-ND) license shall be applied.